Inozyme Pharma Inc
INZY4.000USD
+0.010+0.25%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
0.000USD0.000After-hours (ET)
257.88MMarket Cap
LossP/E TTM
Inozyme Pharma Inc
4.000
+0.010+0.25%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q1
Operating expenses
5.93%25.79M
19.13%27.17M
37.50%24.85M
68.75%27.66M
32.53%24.34M
16.77%22.81M
6.87%18.07M
6.52%16.39M
9.09%18.37M
4.14%19.53M
18.58%16.91M
21.62%15.39M
53.47%16.84M
66.42%18.76M
-49.63%14.26M
32.54%12.65M
38.78%10.97M
--11.27M
--28.32M
--9.55M
53.10%7.91M
--5.16M
R&D expenses
6.63%20.38M
24.97%22.47M
49.09%19.89M
86.51%21.76M
61.18%19.11M
29.96%17.98M
9.43%13.34M
16.58%11.67M
0.36%11.86M
2.11%13.84M
30.44%12.19M
21.74%10.01M
78.92%11.81M
92.60%13.55M
-62.87%9.35M
4.35%8.22M
3.08%6.60M
--7.04M
--25.17M
--7.88M
54.96%6.41M
--4.13M
Depreciation, depletion, and amortization
-3.30%176.00K
-15.31%177.00K
-6.25%195.00K
-10.05%188.00K
-12.08%182.00K
5.56%209.00K
10.05%208.00K
16.76%209.00K
16.29%207.00K
8.79%198.00K
13.17%189.00K
7.19%179.00K
12.66%178.00K
47.97%182.00K
288.37%167.00K
542.31%167.00K
532.00%158.00K
--123.00K
--43.00K
--26.00K
31.58%25.00K
--19.00K
Operating profit
-5.93%-25.79M
-19.13%-27.17M
-37.50%-24.85M
-68.75%-27.66M
-32.53%-24.34M
-16.77%-22.81M
-6.87%-18.07M
-6.52%-16.39M
-9.09%-18.37M
-4.14%-19.53M
-18.58%-16.91M
-21.62%-15.39M
-53.47%-16.84M
-66.42%-18.76M
49.63%-14.26M
-32.54%-12.65M
-38.78%-10.97M
---11.27M
---28.32M
---9.55M
-53.10%-7.91M
---5.16M
Net non-operating interest income (expenses)
Non-operating interest income
-52.95%1.12M
--1.48M
--1.78M
--2.03M
--2.37M
----
----
----
----
----
1468.09%737.00K
453.45%321.00K
-4.76%60.00K
-32.81%43.00K
-26.56%47.00K
-18.31%58.00K
-63.16%63.00K
--64.00K
--64.00K
--71.00K
-18.57%171.00K
--210.00K
Non-operating interest expense
6.11%1.41M
--1.42M
--1.42M
--1.40M
--1.32M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Special income (expenses)
---1.90M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
-21.57%-62.00K
150.00%35.00K
-505.00%-81.00K
89.29%-3.00K
-50.00%-51.00K
-91.95%14.00K
110.15%20.00K
85.34%-28.00K
67.62%-34.00K
535.00%174.00K
-203.08%-197.00K
-435.09%-191.00K
25.53%-105.00K
-144.94%-40.00K
-141.40%-65.00K
1325.00%57.00K
-4600.00%-141.00K
--89.00K
--157.00K
--4.00K
82.35%-3.00K
---17.00K
Income before tax
-20.10%-28.04M
-25.67%-27.07M
-47.67%-24.57M
-73.48%-27.03M
-34.15%-23.35M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.40M
1.12%-18.54M
-14.65%-16.37M
-21.70%-15.26M
-52.80%-16.88M
-68.68%-18.75M
49.17%-14.28M
-32.38%-12.54M
-42.80%-11.05M
---11.12M
---28.09M
---9.47M
-55.66%-7.74M
---4.97M
Income tax
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income after tax
-20.10%-28.04M
-25.67%-27.07M
-47.67%-24.57M
-73.48%-27.03M
-34.15%-23.35M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.40M
1.12%-18.54M
-14.65%-16.37M
-21.70%-15.26M
-52.80%-16.88M
-68.68%-18.75M
49.17%-14.28M
-32.38%-12.54M
-42.80%-11.05M
---11.12M
---28.09M
---9.47M
-55.66%-7.74M
---4.97M
Net income from continuous operations
-20.10%-28.04M
-25.67%-27.07M
-47.67%-24.57M
-73.48%-27.03M
-34.15%-23.35M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.40M
1.12%-18.54M
-14.65%-16.37M
-21.70%-15.26M
-52.80%-16.88M
-68.68%-18.75M
49.17%-14.28M
-32.38%-12.54M
-42.80%-11.05M
---11.12M
---28.09M
---9.47M
-55.66%-7.74M
---4.97M
Net income attributable to controlling interests
-20.10%-28.04M
-25.67%-27.07M
-47.67%-24.57M
-73.48%-27.03M
-34.15%-23.35M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.40M
1.12%-18.54M
-14.65%-16.37M
-21.70%-15.26M
-52.80%-16.88M
-68.68%-18.75M
49.17%-14.28M
-32.38%-12.54M
-42.80%-11.05M
---11.12M
---28.09M
---9.47M
-55.66%-7.74M
---4.97M
Net income attributable to common shareholders
-20.10%-28.04M
-25.67%-27.07M
-47.67%-24.57M
-73.48%-27.03M
-34.15%-23.35M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.40M
1.12%-18.54M
-14.65%-16.37M
-21.70%-15.26M
-52.80%-16.88M
-68.68%-18.75M
49.17%-14.28M
-32.38%-12.54M
-42.80%-11.05M
---11.12M
---28.09M
---9.47M
-55.66%-7.74M
---4.97M
Basic earnings per share
-15.41%-0.44
-21.03%-0.42
-32.46%-0.39
-25.63%-0.44
5.05%-0.38
17.79%-0.35
21.83%-0.29
9.63%-0.35
44.16%-0.40
46.55%-0.42
37.91%-0.38
28.00%-0.38
-51.14%-0.71
-67.10%-0.79
49.77%-0.60
-31.67%-0.53
-23.82%-0.47
---0.47
---1.20
---0.41
-55.66%-0.38
---0.24
Diluted earnings per share
-15.41%-0.44
-21.03%-0.42
-32.46%-0.39
-25.63%-0.44
5.05%-0.38
17.79%-0.35
21.83%-0.29
9.63%-0.35
44.16%-0.40
46.55%-0.42
37.91%-0.38
28.00%-0.38
-51.14%-0.71
-67.10%-0.79
49.77%-0.60
-31.67%-0.53
-23.82%-0.47
---0.47
---1.20
---0.41
-55.66%-0.38
---0.24
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
